Combining pioneering science with the power of nature

Learn more

Who is Apollon

Apollon’s strategy is to become the proven global medical cannabis company licensed to develop full spectrum formulations based on real life clinical patient data.

It aims to create a globally recognised brand synonymous with quality, consistency potency on a range of products for a variety of conditions within the medical cannabis space.

Learn more about Apollon

Our Strategy

Our strategy is to become the premiere global medical cannabis company legally licensed to develop successful personalised clinical treatments utilizing artificial intelligence on patient data.

Apollon’s Research & Development Licence allows drug discovery using THC and other cannabinoids. This allows Apollon to be the rare European listed company conducting medically supervised treatments using THC to develop new therapeutics.